This project aims to investigate if the contraceptive method, Phexxi, causes changes to the composition of the vaginal microbiome. The investigators hypothesize that regular use of Phexxi will cause increased colonization of lactic acid-producing lactobacilli, which could have positive effects in the way of preventing recurrent episodes of BV and candida infections.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
To assess participant's baseline vaginal microbiome makeup
Timeframe: Within one week of recruitment, unless menstruating. If this is the case, the participant will be asked to wait 10 days from the cessation of menses in order to allow restoration of baseline vaginal microbiome
To assess if the use of Phexxi causes changes in the vaginal microbiome from baseline after thirty days of use
Timeframe: 30 days after baseline vaginal swab collection
To assess if the use of Phexxi causes changes in the vaginal microbiome
Timeframe: 60 days after baseline vaginal swab collection
To assess participant's baseline vulvovaginitis symptoms
Timeframe: On day of recruitment to the study
To assess if the use of Phexxi decreases vulvovaginitis symptoms in study participants
Timeframe: 30 days after baseline vaginal swab collection
To assess if the use of Phexxi decreases vulvovaginitis symptoms in study participants
Timeframe: 60 days after baseline vaginal swab collection